Arishita G I, Cruz B K, Harding C T, Arbutina D R
Department of Surgery, David Grant USAF Medical Center, Travis Air Force Base, California 94535-5300.
J Surg Oncol. 1991 Nov;48(3):153-7. doi: 10.1002/jso.2930480303.
A prospective study was undertaken to evaluate the effectiveness of mammogram directed fine-needle aspiration cytology in women with nonpalpable abnormalities detected on mammogram. Seventy patients were entered into the research protocol, with 61 patients undergoing mammogram directed fine-needle aspiration. Forty-three of the aspirates were adequate for diagnosis. Fine-needle aspiration yielded an accurate diagnosis in 12 of the 14 carcinomas in which the sample was considered adequate, for a sensitivity of 87%. No patients were falsely diagnosed with malignant disease, a specificity of 100%. The predictive value of a positive test was 100%, and that of a negative test was 93%. We conclude that fine-needle aspiration cytology can aid in making a diagnosis when nonpalpable breast abnormalities are detected on mammogram.
开展了一项前瞻性研究，以评估乳腺钼靶引导下细针穿刺细胞学检查对乳腺钼靶检查发现的不可触及异常女性的有效性。70例患者纳入研究方案，其中61例患者接受了乳腺钼靶引导下细针穿刺。43例穿刺样本足够用于诊断。在样本被认为足够的14例癌中，细针穿刺在12例中得出了准确诊断，敏感性为87%。没有患者被误诊为恶性疾病，特异性为100%。阳性试验的预测值为100%，阴性试验的预测值为93%。我们得出结论，当乳腺钼靶检查发现不可触及的乳腺异常时，细针穿刺细胞学检查有助于做出诊断。
